A Multi-Model Strategy for Optimizing Hepatitis B Virus preS1 Epitope Recognition by the Antibody HzKR127
Current Issues in Molecular Biology · 03.08.2026 · 48 (8) · 791
DOI: 10.3390/cimb48080791 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 03.08.2026. Verfasst von Wenqing Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Strategic Priority Research Program of CAS.
Abstract (Originalsprache)
Functional cure of chronic hepatitis B virus (HBV) infection remains a significant challenge, making viral-entry-blocking antibodies a promising antiviral strategy. Here, we developed a structure-guided computational workflow for affinity-enhancing candidate mutations at the interface between the humanized neutralizing antibody HzKR127 and the HBV preS1 peptide epitope. Based on the crystal structure of the HzKR127–preS1 complex, we performed single-site saturation mutagenesis across the paratope, evaluating variants with a consensus effect score integrated from seven computational models. Benchmarking against published alanine scanning data showed that our consensus score effectively identified major-affinity-loss residues, achieving ROC AUC values of 0.81 and 0.84 for residue-level and site-level predictions, respectively. Mutational profiling revealed distinct asymmetric mutational responses, with broad intolerance on the preS1 side and localized favorable substitutions within antibody CDRs. Multilevel prioritization identified 26 antibody-side candidates, 17 of which showed improved HADDOCK refinement scores compared to the wild type. In particular, the H:D97W/F/Y substitutions presented the strongest structural rationale for enhancing improved interfacial packing through aromatic hydrophobic contacts with preS1 Phe10. These findings provide a prioritized list of candidates for experimental validation and a practical framework for the rational optimization of antibodies targeting functionally constrained viral epitopes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
- Key Laboratory of Epigenetic Regulation and Intervention, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
ORCID-Profile: Yanan Gao
Förderung
- National Natural Science Foundation of China
- National Key R&D Program of China
- Strategic Priority Research Program of CAS
- Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Project
- Chongqing Medical Key Discipline and Regional Medical Key Discipline Development Project
Zitieren
APA
Chen, W., Tu, Y., Wang, K., Xie, R., Yang, P., Gao, Y., & Huang, W. (2026). A Multi-Model Strategy for Optimizing Hepatitis B Virus preS1 Epitope Recognition by the Antibody HzKR127. Current Issues in Molecular Biology, 48(8), 791. https://doi.org/10.3390/cimb48080791
Vancouver
Chen W, Tu Y, Wang K, Xie R, Yang P, Gao Y, et al. A Multi-Model Strategy for Optimizing Hepatitis B Virus preS1 Epitope Recognition by the Antibody HzKR127. Current Issues in Molecular Biology. 2026;48(8):791. doi:10.3390/cimb48080791
BibTeX
@article{Chen2026,
author = {Chen, Wenqing and Tu, Yuanzhong and Wang, Kai and Xie, Runze and Yang, Pengyuan and Gao, Yanan and Huang, Wenxiang},
title = {A Multi-Model Strategy for Optimizing Hepatitis B Virus preS1 Epitope Recognition by the Antibody HzKR127},
journal = {Current Issues in Molecular Biology},
year = {2026},
volume = {48},
number = {8},
pages = {791},
doi = {10.3390/cimb48080791}
}
EUVIMED